Employees
75k
Overview
Merck & Co. is a multinational pharmaceutical company headquartered in Rahway, New Jersey. Outside the United States and Canada it does business as Merck Sharp & Dohme (MSD).
Verified record
- Verified deployments
- None on file
- Active incidents
- None on file
Key facts
Industry
Products
Area served
Revenue (2025)
Data & sources
Web sources
1
1 source backing this record.View all →
Partnerships
Every company Merck & Co. has built with, alongside the ones only announced in a press release.
Merck & Co. on the deployment map
View the global mapMerck & Co. has no verified deployments on the DEPLOY registry yet. Explore the deployment map by place and type.
No verified deployments for Merck & Co. on the DEPLOY record yet. Track Merck & Co. to know the moment the first one is verified.
Relationships
Current leadership (3)
- Robert M. Davis Chairman, President & CEOsecondary-verified
- Caroline Litchfield CFOsecondary-verified
- Dean Y. Li President, Merck Research Laboratoriessecondary-verified
Former / Previously (2)
- George Merck Co-foundersecondary-verified
- Theodore Weicker Co-foundersecondary-verified
Safety record
No incidents on record for Merck & Co..
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Full safety record: incidents, sourcing, and exposure data →
Merck & Co. on the data-center map
Every verified data center Merck & Co. operates that has a mapped coordinate (1 total). Filled circles are Tier-2 facilities and Tier-1 campuses under this operator; click any pin to open its record.
Merck & Co. data centers (1)
- Merck Kenilworth Data CenterKenilworth · operating
AI data centers Merck & Co. operates or is a party to, from the DEPLOY data center registry.
Recent coverage
Merck & Co. in third-party press
Financial state
- Employees
- 75,000(reported)
Each numeric field carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.
Partnerships
2 total · 2 operating
Every company Merck & Co. has built with, alongside the ones only announced in a press release.
All 2 partnerships
open in the atlas →- Merck & Co. x AWSwithAWS30technology—operating
- Merck & Co. x NVIDIAwithNVIDIA134technology—operating
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Record createdAug 20, 2026
Added to the verified registry
Sources (1)
Common questions
What is Merck & Co.?
What does Merck & Co. make?
Is Merck & Co. publicly traded?
Who is the CEO of Merck & Co.?
How can I invest in Merck & Co.?
Where is Merck & Co. headquartered?
Who owns Merck & Co.?
Is Merck & Co. a top robotics company?
When was Merck & Co. founded?
Is Merck & Co. safe?
Methodology: Verified · 1 source (no primary) · last reviewed 2026-10-22
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-10-22
Sources by quality tier
- 1
- knowledge-base
- Knowledge base
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Merck & Co..In the press
Recent coverage mentioning Merck & Co. from third-party publications. Automatically surfaced; not part of the verified registry record.
QRG Capital Management Inc. Lowers Holdings in Merck & Co., Inc. $MRK
Zifo Co-Launches REAL 2026 to Spotlight the Next Generation of Connected, AI-Enabled Lab Environments
Moderna stock price skyrockets on mRNA cancer vaccine trial news: Here’s what’s happening
Earnings Preview: What To Expect From Merck & Co.'s Report
Former Merck and NASA Veterans Join SpaceMD as Space Pharma Momentum Builds
ASCO26: Solid tumour data readouts outline Merck & Co’s oncology prowess
Merck's (NYSE:MRK) Soft Earnings Don't Show The Whole Picture
Merck’s new AI strategy ‘reimagining engagement with HCPs’
An ‘AI scientist’ can tackle drug R&D. What does that mean for pharma?
Infinimmune, Merck enter into antibody discovery pact
SK bioscience accelerates development of next-gen Ebola vaccine
Merck inks $349M biobucks deal to apply AI to challenging targets
Machine-readable surfaces
- Markdown mirror: /companies/merck-co.md
- RSS feed: /companies/merck-co/feed.xml
- JSON-LD: embedded in this page’s head
- REST API: /v1/companies/779d71cf-0f88-4ef6-b75e-c9eee1bfa399
- Revision history: /companies/merck-co/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Heat Index
Serious54/100
A composite of competitive footprint, funding, press velocity, active partnerships, and supply-chain edges. Different from the Intelligence score below (which is per-form-factor productization). Non-robotics companies cap at 25.
Reality vs attention
Not enough verified signal yet to place Merck & Co. against peers. Reality and attention percentiles publish once the underlying record clears its data floor.
6-month trend
Analysis
Limited public visibility and press coverage relative to peers.
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Nov 21, 2026